320 likes | 402 Views
Skin Cancer Update 2012. Peter Ehrnstrom, MD, FAAD, FASDS alaska center for dermatology, p.c. May 11, 2012. Types of Skin Cancer. Basal cell carcinoma (BCC) Squamous cell carcinoma (SCC) Melanoma DFSP AFX Mets (breast, colon, renal, lung, melanoma…) Unusual tumors
E N D
Skin Cancer Update 2012 Peter Ehrnstrom, MD, FAAD, FASDS alaska center for dermatology, p.c. May 11, 2012
Types of Skin Cancer • Basal cell carcinoma (BCC) • Squamous cell carcinoma (SCC) • Melanoma • DFSP • AFX • Mets (breast, colon, renal, lung, melanoma…) • Unusual tumors • Leiomyosarcoma, 1oadenoca, malig neural sheath tumor, sebaceous carcinoma, Merkel cell ca, angiosarcoma, microcysticadnexal carcinoma
Skin Cancer • Who gets skin cancer? • Genetics • Melanoma especially • Personal history • Primary relative • UV exposure • Sun, tanning beds • Early and intermittent exposure • Rare causes • Viruses • Genetic disorders • Xeroderma pigmentosa • Basal Cell Nevus Syndrome
Mohs Surgery • Developed in 1930s by Frederic Mohs at University of Wisconsin • Highest cure rates for contiguously growing tumors while being tissue sparing as well • Labor- and time-intensive
Indications for Mohs • Head and neck • >2 cm elsewhere • Aggressive growth tumors • Recurrent tumors • Ill-defined margins
Sonic Hedgehog and BCC • SHH signaling crucial for embryo development • Left-right and up-down • SHH signaling in adult necessary for normal stem cell growth • Abnormal signaling likely turns adult stem cells into cancer stem cells—especially in skin (leading to BCC) but also in brain, lung, breast and prostate
Vismodegib (Erivedge®) • Therapy for metastatic BCC, intractable or inoperable/otherwise untreatable BCC • Competitive antagonist of one of the receptors in the SHH-signaling pathway • Prevents expression of genes leading to tumor growth from abnormal SHH-signaling • Possible uses in many other tumors • Drugs causing opposite effect might be helpful post-MI or post-stroke
Melanoma treatment • In situ • 0.5-cm margins • > in situ but <1.0 mm with no “bad signs” • 1.0-cm margins • 1.0-4.0 mm with no bad signs • At least 1.0-cm margins + SLN bx • >4.0 mm • Add possible interferon • Any depth with mets • Interferon and/or immunotherapy and/or GMCSF • Possibly vemurafenib • Bad signs • Ulceration, high mitotic rate, and possibly regression
Vemurafenib (Zelboraf®) • ~60% of melanomas have mutation at V600E BRAF gene (glutamic acid instead of valine) • Vemurafenib inhibits one of the steps in the B-Raf pathway thereby leading to programmed cell death • May actually promote tumor growth in melanomas without this mutation • Very helpful but resistance develops
Protection From DNA Damage That Leads to Cancer • Behavior modification • Clothing and hats • Sunscreen • Bottom line: Don’t change the color of your skin through radiation exposure!
Myths • Indoor tanning is safe • I need 15 minutes of sun exposure per day to keep my vitamin D levels up • Pre-tanning will make my vacation exposure safer
Skin Cancer Update 2012 Peter Ehrnstrom, MD, FAAD, FASDS alaska center for dermatology, p.c. May 11, 2012
Peter Ehrnstrom, MDPeggy O’Reilly, MDRobert Moreland, MDKim Kinnebrew, PA-CCarmen T’Joens, PA-C (907) 646-8500